Cathie Wood's ARK Genomic Revolution Stocks Performance Guide: Guardant Health, Inc. (GH)
GH has no dividends.
Table and Chart of GH Performance
See what a $1,000 investment in GH is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| GH Returns | |
|---|---|
| Start Date | Nov-30-2018 |
| Start Price | $35.73 |
| End Date | May-17-2024 |
| End Price | $25.36 |
| # Prices | 67 |
| Min Date | Apr-30-2024 |
| Min Price | $18.00 |
| Max Date | Apr-30-2021 |
| Max Price | $158.98 |
| Total Return | -29.02% |
| Annualized Return | -5.96% |
| Current Value of $1,000 Purchase | $710 |
| Number Returns | 2,211 |
| Average Return | -15.96% |
| Number Profitable Returns | 681 |
| Percent Profitable Returns | 30.80% |
| Number Unprofitable Returns | 1,530 |
| Percent Unprofitable Returns | 69.20% |
| Profitable to Unprofitable Returns Ratio | 0.45 |
| GH Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,103,278,000 |
| Beta | 0.921 | Price to Sales | 3.94 |
| Earnings per Share | $-3.9200 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 14.01 |
| PRICE DATA | |
| 52 Week High | $41.06 |
| 52 Week Low | $15.81 |
| Analyst Target Price | $35.94 |
| 50-Day Moving Average | $19.01 |
| 200-Day Moving Average | $25.12 |
| FINANCIAL DATA | |
| Revenue per Share | $5.17 |
| Revenue | $603,725,000 |
| Profit Margin | -76.3% |
| Return on Equity | -3884% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
GH Compare Returns with S&P 500
GH Trendline Chart
GH Moving Average Chart
GH Stock Return Map - See Patterns of Gains and Losses
GH Stock Returns/Purchase Dates